PharVision Advisers’s Harley-Davidson HOG Stock Holding History

PharVision Advisers’s Portfolio HOG Stock Details HOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,858	Closed	-$359K	–	827
2025 Q3	$359K	Buy	+12,858	New	+$345K	0.2%	132

Other funds holding HOG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DSC

Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BGC

Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HPM

H. Partners Management New York $154M AUM 19.94% 1-Year Est. Return

PharVision Advisers's HOG Position: Q4 2025 in Review

PharVision Advisers sold out of Harley-Davidson (HOG) in Q4 2025, closing a stake of 12,858 shares — an estimated $359K sold.

PharVision Advisers first reported a position in HOG in Q3 2025 and held it in 1 quarter. The position peaked at $359K in Q3 2025. 386 funds tracked by Wall St. Rank hold HOG as of Q4 2025.

PharVision Advisers reported no remaining Harley-Davidson position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 12,858 Harley-Davidson shares in Q4 2025, an estimated $359K.
PharVision Advisers first reported a position in Harley-Davidson in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Harley-Davidson position peaked at $359K in Q3 2025.
386 funds tracked by Wall St. Rank held Harley-Davidson as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.